Identification and characterization of polyclonal αβ-T cells with dendritic cell properties

Nature Communications

Volumn 3, Issue , 2012, Pages

  Kuka, Mirela ^a   Munitic, Ivana ^a   Ashwell, Jonathan D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; GLYCOPROTEIN P 15095; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYCLONAL ALPHA BETA T CELL RECEPTOR; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN; CELL ORGANELLE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNE SYSTEM; RODENT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN;

ANIMALS; ANTIGENS, CD11C; DENDRITIC CELLS; GENES, MHC CLASS II; HLA-DR ALPHA-CHAINS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, NUDE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYMUS GLAND;

MUS;

EID: 84870799837     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2223     Document Type: Article

References (43)

1. Moser, M. & Leo, O. Key concepts in immunology. Vaccine 28(Suppl 3): C2-13 (2010).
2. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
3. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
4. Liu, K. & Nussenzweig, M. C. Origin and development of dendritic cells. Immunol. Rev. 234, 45-54 (2010).
5. Mak, K. S., Funnell, A. P., Pearson, R. C. & Crossley, M PU.1 and haematopoietic cell fate: dosage matters. Int. J. Cell Biol. 2011, 808524 (2011).
6. Satpathy, A. T., Murphy, K. M. & Kc, W. Transcription factor networks in dendritic cell development. Semin. Immunol. 23, 388-397 (2011).
7. Meredith, M. M. et al. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J. Exp. Med. 209, 1153-1165 (2012).
8. Satpathy, A. T. et al. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 209, 1135-1152 (2012).
9. McKenna, H. J. et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95, 3489-3497 (2000).
10. Love, P. E. & Bhandoola, A. Signal integration and crosstalk during thymocyte migration and emigration. Nat. Rev. Immunol. 11, 469-477 (2011).
11. Yang, Q., Jeremiah Bell, J. & Bhandoola, A T-cell lineage determination. Immunol. Rev. 238, 12-22 (2010).
12. Masuda, K. et al. T cell lineage determination precedes the initiation of TCR beta gene rearrangement. J. Immunol. 179, 3699-3706 (2007).
13. Moore, A. J. et al. Transcriptional priming of intrathymic precursors for dendritic cell development. Development 139, 373-384 (2012).
14. Yui, M. A., Feng, N. & Rothenberg, E. V. Fine-scale staging of T cell lineage commitment in adult mouse thymus. J. Immunol. 185, 284-293 (2010).
15. Wu, L. & Van Kaer, L. Natural killer T cells in health and disease. Front. Biosci. 3, 236-251 (2011).
16. Bonneville, M., O'Brien, R. L. & Born, W. K. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10, 467-478 (2010).
17. Kabelitz, D. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19, 39-45 (2007).
18. Komai-Koma, M., Jones, L., Ogg, G. S., Xu, D. & Liew, F. Y. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl Acad. Sci. USA. 101, 3029-3034 (2004).
19. Beyer, M. et al. The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo. Respir. Res. 6, 70 (2005).
20. Huleatt, J. W. & Lefrancois, L. Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. J. Immunol. 154, 5684-5693 (1995).
21. Lin, Y., Roberts, T. J., Sriram, V., Cho, S. & Brutkiewicz, R. R. Myeloid marker expression on antiviral CD8+ T cells following an acute virus infection. Eur. J. Immunol. 33, 2736-2743 (2003).
22. Rechavi, O., Goldstein, I. & Kloog, Y. Intercellular exchange of proteins: the immune cell habit of sharing. FEBS Lett. 583, 1792-1799 (2009).
23. Schooten, E., Klous, P., van den Elsen, P. J. & Holling, T. M. Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region. Immunogenetics 57, 795-799 (2005).
24. Wang, L. et al. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+) T cells. Nat. Immunol. 9, 1122-1130 (2008).
25. Mach, N. et al. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 60, 3239-3246 (2000).
26. Waskow, C. et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9, 676-683 (2008).
27. Kaye, J., Vasquez, N. J. & Hedrick, S. M. Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. J. Immunol. 148, 3342-3353 (1992).
28. Matechak, E. O., Killeen, N., Hedrick, S. M. & Fowlkes, B. J. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. Immunity 4, 337-347 (1996).
29. Smith-Garvin, J. E., Koretzky, G. A. & Jordan, M. S. T cell activation. Annu. Rev. Immunol. 27, 591-619 (2009).
30. Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).
31. Holling, T. M., Schooten, E. & van Den Elsen, P. J. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum. Immunol. 65, 282-290 (2004).
32. Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L. & Sisirak, V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29, 163-183 (2011).
33. Van Kaer, L. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19, 354-364 (2007).
34. Van Kaer, L., Parekh, V. V. & Wu, L. Invariant natural killer T cells: bridging innate and adaptive immunity. Cell Tissue Res. 343, 43-55 (2011).
35. Anderson, M. K., Weiss, A. H., Hernandez-Hoyos, G., Dionne, C. J. & Rothenberg, E. V. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity 16, 285-296 (2002).
36. Ishifune, C. et al. Notch signaling regulates the development of a novel type of Thy1-expressing dendritic cell in the thymus. Eur. J. Immunol. 41, 1309-1320 (2011).
37. Lewis, K. L. et al. Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity 35, 780-791 (2011).
38. Lieberman, J Granzyme A activates another way to die. Immunol. Rev. 235, 93-104 (2010).
39. Martinvalet, D., Dykxhoorn, D. M., Ferrini, R. & Lieberman, J. Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death. Cell 133, 681-692 (2008).
40. Zangi, L. et al. Deletion of cognate CD8 T-cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1 and TLR7. Blood 120, 1647-1657 (2012).
41. Kerkar, S. P. et al. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J. Clin. Invest. 121, 4746-4757 (2011).
42. Zhang, L. et al. Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment. Mol. Ther. 19, 751-759 (2011).
43. Kerkar, S. P. et al. Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts. Cancer Res. 70, 6725-6734 (2010).